Sickle SCAN® EZ: Empowering Large-Scale Sickle Cell Diagnostics with Cutting-Edge Simplicity

Facilitating Sickle Cell Disease Diagnostics with Sickle SCAN EZ

BioMedomics revolutionized diagnostics for Sickle Cell Disease (SCD) and Sickle Cell Trait (SCT) with Sickle SCAN®, the world’s first Point-of-Care Test (POCT). Building on this legacy, we are excited to introduce Sickle SCAN EZ, designed to complement the original Sickle SCAN® with the strip configuration in a bulk packaging tailored for high-volume screening, all while retaining the same industry-leading technology.

Frank Wang, PhD, founder and CEO of BioMedomics, expressed his commitment to patients, stating “At BioMedomics, our commitment to advancing healthcare for Sickle Cell Disease patients drives every innovation. The launch of Sickle SCAN EZ marks one step further to diagnose SCD patients, and also confirms our dedication to empowering clinicians with rapid, reliable solutions that transform patient care. Our core technology ensures accuracy, efficiency, and accessibility to patients around the globe.”

Why Choose Sickle SCAN® EZ?

Sickle SCAN® EZ maintains the trusted technology of the original Sickle SCAN®:

Rapid Results: Clear, actionable results in just 5 minutes.

Accurate: Sensitivity and specificity rates exceeding 99%.

Ease of Use: Requires no specialized training or equipment.

Portable: Operates without electricity, ideal for diverse environments.

Comprehensive Testing: Differentiates HbA, HbAS, HbSS, and HbSC.

How Does It Complement Sickle SCAN®?

While Sickle SCAN® (cassette) serves as the rapid diagnostic tool of choice for individual or small-scale use, Sickle SCAN® EZ (strip) excels in high-volume settings, such as public health initiatives, laboratories, and community screening events, with lower price.

Xingzhou Liu, MD, MBA, VP and Chief Commercial Officer of BioMedomics, emphasized the company’s commitment to expanding access to Sickle SCAN EZ. “Our goal is to reach more patients in need, by working closely with our distribution partners to ensure that patients, no matter where they are, benefit from our technology. With Sickle SCAN EZ, we can support large-scale screening programs that bring timely diagnosis and care to underserved regions. Together, we can make a real difference in the fight against Sickle Cell Disease.”

For any inquiries or questions regarding Sickle SCAN EZ, please contact info@biomedomics.com or sales@biomedomics.com.